Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Minimally invasive in tumor multidrug comparative analysis with contrast-enhanced MRI in mice.

Kerwin WS, Tretyak I, Grenley MO, You S, Hatton BA, Moreno-Gonzalez A, Thirstrup DJ, Klinghoffer RA.

Magn Reson Med. 2016 Sep;76(3):946-52. doi: 10.1002/mrm.25978. Epub 2015 Sep 12.

PMID:
26362018
2.

A technology platform to assess multiple cancer agents simultaneously within a patient's tumor.

Klinghoffer RA, Bahrami SB, Hatton BA, Frazier JP, Moreno-Gonzalez A, Strand AD, Kerwin WS, Casalini JR, Thirstrup DJ, You S, Morris SM, Watts KL, Veiseh M, Grenley MO, Tretyak I, Dey J, Carleton M, Beirne E, Pedro KD, Ditzler SH, Girard EJ, Deckwerth TL, Bertout JA, Meleo KA, Filvaroff EH, Chopra R, Press OW, Olson JM.

Sci Transl Med. 2015 Apr 22;7(284):284ra58. doi: 10.1126/scitranslmed.aaa7489.

3.

Prognostic value and functional consequences of cell cycle inhibitor p27Kip1 loss in medulloblastoma.

Hatton BA, Ellison DW, Gajjar A, Kool M, Fero M, Olson JM.

Biomark Res. 2013 Mar 1;1(1):14. doi: 10.1186/2050-7771-1-14.

4.

A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel transgenic mouse model.

Dey J, Ditzler S, Knoblaugh SE, Hatton BA, Schelter JM, Cleary MA, Mecham B, Rorke-Adams LB, Olson JM.

Mol Cell Biol. 2012 Oct;32(20):4104-15. Epub 2012 Aug 6.

5.

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model.

Lee MJ, Hatton BA, Villavicencio EH, Khanna PC, Friedman SD, Ditzler S, Pullar B, Robison K, White KF, Tunkey C, LeBlanc M, Randolph-Habecker J, Knoblaugh SE, Hansen S, Richards A, Wainwright BJ, McGovern K, Olson JM.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7859-64. doi: 10.1073/pnas.1114718109. Epub 2012 May 1.

6.

Notch signaling is not essential in sonic hedgehog-activated medulloblastoma.

Hatton BA, Villavicencio EH, Pritchard J, LeBlanc M, Hansen S, Ulrich M, Ditzler S, Pullar B, Stroud MR, Olson JM.

Oncogene. 2010 Jul 1;29(26):3865-72. doi: 10.1038/onc.2010.142. Epub 2010 May 3.

7.

The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.

Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG, Hallahan AR, Olson JM.

Cancer Res. 2008 Mar 15;68(6):1768-76. doi: 10.1158/0008-5472.CAN-07-5092.

8.

N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth.

Hatton BA, Knoepfler PS, Kenney AM, Rowitch DH, de Alborán IM, Olson JM, Eisenman RN.

Cancer Res. 2006 Sep 1;66(17):8655-61.

9.

The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.

Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, Russell TL, Ellenbogen RG, Bernstein ID, Beachy PA, Olson JM.

Cancer Res. 2004 Nov 1;64(21):7794-800.

Supplemental Content

Loading ...
Support Center